Axcan Pharma Inc.
TSX : AXP
NASDAQ : AXCA

Axcan Pharma Inc.

September 19, 2007 15:00 ET

Axcan Pharma to Present at the UBS Global Life Sciences Conference

MONT-SAINT-HILAIRE, QUEBEC--(Marketwire - Sept. 19, 2007) - Axcan Pharma Inc. ("Axcan" or the "Company") (TSX:AXP)(NASDAQ:AXCA) today announced that on Wednesday, September 26, 2007, President and Chief Executive Officer, Frank Verwiel, M.D., will present an overview of the Company at the UBS Global Life Sciences Conference to be held in New York City, NY. This presentation will take place at 10:00 a.m. Eastern time.

A webcast of Axcan's presentation will also be accessible via the Company's website at www.axcan.com.

ABOUT AXCAN PHARMA

Axcan is a leading multinational specialty pharmaceutical company focused on gastroenterology. The company develops and markets a broad line of prescription products to treat a range of gastrointestinal diseases and disorders such as inflammatory bowel disease, irritable bowel syndrome, cholestatic liver diseases and complications related to pancreatic insufficiency. Axcan's products are marketed by its own specialized sales forces in North America and Europe. Its common shares are listed on the NASDAQ Global Market under the symbol "AXCA" and on the Toronto Stock Exchange under the symbol "AXP".

Contact Information

  • Axcan Pharma inc.
    Isabelle Adjahi
    Senior Director, Investor Relations and Communications
    450-467-2600, poste 2000
    www.axcan.com